MULTICENTER STUDY
Add like
Add dislike
Add to saved papers

[New "PATE 2006" system for classifying hemorrhoidal disease: advantages resulting from revision of "PATE 2000 Sorrento"].

In 2000 the Italian Society of Coloproctology introduced a novel system for classifying hemorrhoidal disease, PATE 2000 Sorrento, capable of assuring a better knowledge of such pathology. After several studies had established the efficacy of this classification system in comparison to anatomical criteria such as the size and dislocation of hemorrhoids in the anal canal, the need was felt to correct the limits of PATE 2000 Sorrento. Important parameters in assessing the severity of hemorrhoidal disease, such as numerical scores, symptom severity analysis and quality of life analyses, were introduced in PATE 2006 classification. The authors then tested the PATE 2006 on 500 patients with hemorrhoidal disease over a period of two years, referred to 4 different centres. The numerical scores of the PATE 2000 Sorrento factors, quality of life and the severity of symptoms introduced with this classification proved to be important parameters for evaluating hemorrhoids. In conclusions, PATE 2006 seems to be an improvement over the PATE 2000 Sorrento classification system in terms of its efficacy in establishing the more appropriate treatment for each patients with hemorrhoid disease.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app